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Pellino3 targets RIP1 and regulates the
pro-apoptotic effects of TNF-a
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Tumour necrosis factor-a (TNF) can activate NF-kB to induce pro-inflammatory genes but
can also stimulate the caspase cascade to promote apoptosis. Here we show that deficiency
of the ubiquitin E3 ligase, Pellino3, sensitizes cells to TNF-induced apoptosis without inhi-
biting the NF-kB pathway. Suppressed expression of Pellino3 leads to enhanced formation of
the death-induced signalling complex, complex II, in response to TNF. We show that Pellino3
targets RIP1, in a TNF-dependent manner, to inhibit TNF-induced complex II formation and
caspase 8-mediated cleavage of RIP1 in response to TNF/cycloheximide co-stimulation.
Pellino3-deficient mice also show increased sensitivity to TNF-induced apoptosis and greatly
increased lethality in response to TNF administration. These findings define Pellino3 as a
novel regulator of TNF signalling and an important determining factor in dictating whether
TNF induces cell survival or death.
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T
NF is a pro-inflammatory cytokine that can also regulate
cell proliferation, differentiation and death1. The binding
of TNF to its receptor TNFR1 leads to association of
TNFR1-associated death domain protein (TRADD)2 with the
receptor complex and this initiates signal transduction pathways
culminating in activation of the transcription factor NF-kB and
the MAP kinase pathways3. Although NF-kB serves to protect
cells from cell death, the activation of TNFR1 can also trigger
activation of the caspase cascade resulting in cell death by
apoptosis4. The outcome of TNF stimulation depends on the
sequential formation of different signalling complexes upon
binding of TNF to its receptor1,5–8. The initial association of
TNFR1 with TRADD facilitates the further recruitment of a
number of signalling molecules including receptor interacting
protein 1 (RIP1), TNF receptor-associated factor 2 (TRAF2) or
TRAF5 and the cellular inhibitor of apoptosis proteins (cIAPs)
cIAP1 and cIAP2 to form a signalling complex called complex I
(refs 6, 9, 10). This results in the K63 ubiquitylation of RIP1 by
TRAF-2 (refs 11–14) and the cIAPs15–17 leading to downstream
activation of NF-kB. The activation of NF-kB is dependent on
phosphorylation and degradation of its inhibitory IkB proteins.
The phosphorylation of the latter is catalysed by the IkB kinase
(IKK) complex consisting of two catalytic subunits IKKa and
IKKb and the scaffolding subunit IKKg (also termed NFkB-
essential modulator (NEMO))18–20. Polyubiquitinated RIP1 allows
for interaction with the ubiquitin-binding domain of IKKg21, thus
having an important role in the activation of NF-kB by recruiting
the IKK complex to TNF-R1 (refs 22,23). The recruited IKK
complex may be activated by the upstream kinase TAK1 that is
also recruited to polyubiquitinated RIP1 via the ubiquitin-binding
domains of TAK1-associated proteins termed TABs24–26. Thus,
the K63 polyubiquitination of RIP1 is associated with downstream
activation of NF-kB and the induction of anti-apoptotic genes
such as cellular FLICE Inhibitory protein (c-FLIP) and cIAPs that
prevent cell death27–29. However, NF-kB also upregulates A20 and
CYLD, which remove K63-specific polyubiquitin chains from
RIP1 and abolish its ability to activate NF-kB4,30,31. In its
unubiquitinated form RIP1 can dissociate from TNFR1, with or
without TRADD, to interact with Fas-associated death domain
(FADD) protein that in turn recruits procaspase 8 to form an
intracellular signalling complex (complex II), also called death-
inducing signalling complex (DISC)8,16,30,32,33. The formation of
complex II triggers processing and activation of caspase 8 leading
to initiation of the caspase cascade and ultimately cell death.
Furthermore, caspase 8 can also cleave RIP1 to further promote
TNF-induced apoptosis34.
RIP1 also has a key role in Toll-like receptor (TLR) pathways
and mediates IKK activation in response to signalling by the
TLR3 and TLR4 adaptor protein TRIF35,36. Genetic ablation
experiments have shown Peli1 to be the E3 ubiquitin ligase for
RIP1 in the TLR3/TLR4 pathways37. Peli1 belongs to the
mammalian Pellino family of E3 ubiquitin ligases that is made
up of four family members (Pellino1, Pellino2 and two spliced
variants of Pellino3 (Pellino3s and 3l)38,39. Each member of the
family contains a N-terminal forkhead-associated (FHA) domain,
a phosphothreonine-binding module that facilitates interaction
with IL-1R-associated kinases (IRAKs)40, and a C-terminal
RING-like domain that catalyses K63 polyubiquitination of
IRAKs41–43. The latter are key signalling intermediates in IL-1
and TLR pathways and thus Pellino proteins have been
implicated in these signalling cascades. However the recent
identification of Pellino1 as an E3 ubiquitin ligase for RIP1
suggested to us that Pellino proteins may be able to regulate TNF
signalling. While the role of Pellino1 in TNF signalling was not
explored in Peli1-deficient mice37, earlier studies using gene
knockdown technology in cell lines reported that Pellino1 and
Pellino2 don’t have a role in TNF-induced activation of NF-kB44, 45.
Here we explore the role of Pellino3 in TNF signalling.
We now demonstrate that Pellino3 has an important regulatory
role in the TNF signalling pathway. Knockdown or genetic
deficiency of Pellino3 sensitizes cell to TNF-induced apoptosis
without inhibiting activation of NF-kB. Instead, loss of Pellino3
leads to increased complex II formation in response to TNF and
we show that Pellino3 can normally regulate TNF-induced
complex II generation and caspase 8-mediated cleavage of RIP1
by targeting RIP1 in a manner that is dependent on the FHA
domain but independent of the RING-like domain of Pellino3.
Pellino3-deficient mice also show greatly increased sensitivity to
TNF-induced hepatotoxicity and ultimately lethality, thus
emphasizing a physiological role of Pellino3 in determining cell
fate in response to TNF challenge.
Results
Knockdown of Pellino3 enhances pro-apoptotic effects of TNF.
Previous reports had indicated that Pellino1 and Pellino2 don’t
have a role in TNF signalling44,45 but the lack of any data
exploring the role of Pellino3 in the TNF pathway prompted the
present study. We initially used the Hela cell system in
conjunction with Pellino3-specific shRNA to assess the effects
of Pellino3 knockdown on TNF-induced apoptosis. TNF is well
known to cause cell death in the presence of protein synthesis
inhibitors by virtue of the latter preventing the induction of anti-
apoptotic proteins. Thus, the combined treatment of Hela cells
with TNF and cycloheximide caused the cells to become rounded
and non-adherent but the number of such cells was greatly
increased when Pellino3 expression was suppressed by Pellino3-
specific shRNA (Fig. 1a). A MTT-based viability assay revealed
that these morphological changes were associated with reduced
cell viability in response to TNF and cycloheximide (Fig. 1b).
Such decreased viability was due to increased apoptosis, because
knockdown of Pellino3 expression caused greatly enhanced
annexin V staining of Hela cells when co-treated with TNF and
cycloheximide and this increased staining was not apparent when
cells were treated with the caspase inhibitor ZVAD (Fig. 1c).
Furthermore, reduced Pellino3 expression also led to an increased
cleavage of PARP, caspase 3 and caspase 8 in response to the co-
treatment (Fig. 1d). These molecular apoptotic signatures add
further support to our contention that Pellino3 knockdown
sensitizes cells to the pro-apoptotic effects of TNF/cycloheximide.
The suppression of Pellino3 expression also enhanced the pro-
apoptotic effects of TNF alone, in the absence of cycloheximide,
as demonstrated by increased cell detachment (Supplementary
Fig. S1a) and PARP and caspase 3 cleavage (Supplementary
Fig. S1b) in Pellino3 knockdown Hela cells treated with TNF
alone. In order to assess if the pro-apoptotic effects of suppressed
Pellino3 expression were cell-type-dependent similar studies were
performed in a human astrocytoma cell line 1321N1. The same
effects were apparent in that suppression of Pellino3 expression in
1321N1 cells enhanced the capacity of TNF and cycloheximide to
cause cell detachment and rounding (Supplementary Fig. S1c),
reduce viability (Supplementary Fig. S1d) and promote PARP,
caspase 3 and caspase 8 cleavage (Supplementary Fig. S1e). We
next assessed if Pellino3 knockdown had any effects on the ability
of TNF to activate the NF-kB or p38 and JNK MAP kinase sig-
nalling pathways. The suppression of Pellino3 in 1321N1 cells
failed to regulate the ability of TNF to promote degradation of the
NF-kB inhibitory protein, IkBa or induce activation of p38 or
JNK MAPK (Supplementary Fig. S1f). Given the apparent lack of
role for Pellino3 in these pathways, Pellino3 was next assessed for
its potential to directly regulate complex II formation in response
to TNF/cycloheximide. Using co-immunoprecipitation studies on
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the endogenous signalling proteins we confirmed previous reports
that TNF promotes time-dependent interaction of caspase 8 with
FADD and RIP1 to form complex II in Hela cells (Fig. 1e).
However suppressed expression of Pellino3, using Pellino3-spe-
cific shRNA constructs, resulted in greater levels of RIP1 and
FADD interacting with caspase 8 and such increased complex II
formation is consistent with the greater pro-apoptotic effects of
TNF/cycloheximide in cells where Pellino3 expression is
suppressed.
To further validate the above conclusion that Pellino3 knock-
down enhanced TNF-induced apoptosis we used HEK293 cells to
demonstrate that the independent approaches of employing
shRNA expression constructs or synthesized siRNAs to suppress
Pellino3 expression manifested the same findings in terms
of increasing sensitivity of cells to the pro-apoptotic effects
of TNF. Thus, as was the case with Hela and 1321N1 cells,
Pellino3-specific shRNA increased annexin V staining of HEK293
cells in response to TNF/cycloheximide and this could be blocked
with the caspase inhibitor ZVAD (Fig. 2a). In addition these cells
demonstrated increased levels of cleaved PARP, caspase 3 and
caspase 8 in response to TNF/cycloheximide (Fig. 2b). Further-
more, the knockdown of Pellino3 in HEK293 cells, using
Pellino3-specific siRNA that targets a different region of the
Pellino3 mRNA, also enhanced the pro-apoptotic effects of TNF
alone as evidenced by greater levels of cleaved PARP, caspase 3
and caspase 8 (Supplementary Fig. S2a), increased TUNEL
staining (Supplementary Fig. S2b) and enhanced complex II
formation (Supplementary Fig. S2c). These findings, employing
independent approaches to suppress Pellino3 expression in
different cell lines, provide strong evidence that Pellino3 has a
key role in regulating complex II formation and apoptosis in
response to TNF.
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Figure 1 | Pellino3 knockdown sensitizes Hela cells to TNF/cycloheximide-induced apoptosis. (a–e) Hela cells were infected with lentivirus containing
constructs that encoded control or human Pellino3-specific shRNA. Cells were grown in the presence of puromycin to select for cells showing stable
integration of shRNA constructs. Selected cells were treated in the absence (control) or presence of human TNF (40 ngml 1), cycloheximide (CHX)
(10mgml 1) or the caspase inhibitor benzyloxycarbonyl-valine-alanine-aspartate-fluoromethyl ketone (ZVAD) (20 mM) for 5 h or other indicated
times. (a) Cells were photographed using a phase contrast microscope (bar 20mm). (b) Cells were analysed for cell viability using MTTassays with viability
expressed relative to control shRNA-infected cells treated with CHX alone. ***Po0.001 (two-way ANOVA). (c) Cells were analysed by flow cytometry
for percentage of cells staining positive for annexin V staining. Data represent the mean þ / s.e.m. of three independent experiments; ***Po0.001
(two-way ANOVA). (d) Cell lysates were probed by immunoblotting for expression levels of PARP, caspase 3, caspase 8, Pellino3 and b-actin.
Cleaved forms of PARP and caspase 8 are indicated by arrows. (e) In addition to the indicated treatments all cells were treated with ZVAD to prevent
activation of caspase 8 and cell death. Cell lysates were immunoprecipitated with an anti-caspase 8 antibody and immunoprecipitates were subsequently
analysed for co-precipitated RIP1, FADD and caspase 8 by western blotting. The expression levels of RIP1, FADD, caspase 8 and Pellino3 in whole-
cell lysates (‘input’) were also assessed by western blotting. Full-length images of immunoblots are shown in Supplementary Fig. S8.
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Figure 2 | Pellino3 regulates TNF-induced apoptosis in a FHA-dependent but RING-like domain-independent manner. (a,b) HEK293 cells were infected
with lentivirus containing control or Pellino3-specific shRNA and treated with human TNF (50ngml 1), cycloheximide (CHX) (10 mgml 1) or the caspase
inhibitor ZVAD (20mM). (a) Cells were analysed by flow cytometry for annexin V staining (mean þ / s.e.m. of three independent experiments;
**Po0.01; two-way ANOVA). Immunoblot analysis demonstrating Pellino3 protein knockdown. (b) Cell lysates were immunoblotted for PARP, caspase 3,
caspase 8 and b-actin. Cleaved forms of PARP and caspase 8 are indicated by arrows. (c,d) HEK293 cells, previously transfected with an expression
construct encoding Pellino3-specific shRNA, were transfected with pcDNA3.1 empty vector (EV) or pcDNA3.1 encoding myc-tagged Pellino3s, Pellino3l,
Pellino3s(R131A/S161A)-myc (Pellino3sFHAm), Pellino3l(R155A/S185A)-myc (Pellino3lFHAm), Pellino3s(C360A/C363A)-myc (Pellino3sE3m) and
Pellino3l (C384A/C387A)-myc (Pellino3lE3m). (c) Transfected cells were treated with human TNF (40 ngml 1) and cycloheximide (CHX) (10 mgml 1)
for 5 h and analysed by flow cytometry for percentage of cells staining positive for annexin V staining. Data represent the mean þ / s.e.m. of
three independent experiments; ***Po0.001 (two-way ANOVA). The expression levels of Pellino3, PARP, cleaved caspase 3 and b-actin were measured in
cell lysates by western blotting. (d) In addition to the indicated treatments with TNF and cycloheximide (above) cells were also treated with ZVAD to
prevent activation of caspase 8 and cell death. Cell lysates were immunoprecipitated with an anti-caspase 8 antibody and immunoprecipitates were
subsequently analysed for co-precipitated RIP1, FADD and caspase 8 by western blotting. The expression levels of RIP1, FADD, caspase 8, Pellino3 and
b-actin were measured in whole-cell lysates (‘input’) by western blotting. Full-length images of immunoblots are shown in Supplementary Fig. S9.
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Pellino3 regulates TNF signalling via its FHA domain. We next
assessed the functional contribution of the different domains of
Pellino3 to its regulatory effects on TNF signalling. This was
addressed by experiments that aimed to rescue the phenotypic
effects of Pellino3 knockdown on TNF signalling in HEK293 cells,
using various mutant forms of Pellino. The use of a Pellino3-
specific shRNA that targets the 30 untranslated region (UTR) of
the Pellino3 mRNA provided an opportunity to demonstrate that
expression constructs encoding either spliced form of Pellino3 but
lacking the 30 UTR could rescue the increased pro-apoptotic
effects of TNF that was observed in Pellino3 knockdown cells.
Both Pellino3s and Pellino3l prevented the increased annexin V
staining and PARP and caspase 3 cleavage that was apparent in
knockdown cells (Fig. 2c), indicating that both spliced forms can
temper the pro-apoptotic signalling of TNF. Furthermore, the
mechanistic basis to these effects are due to Pellino3 inhibiting
complex II formation in response to TNF/cycloheximide as
shown by the ability of both Pellino3s (Fig. 2d, upper panels) and
Pellino3l (Fig. 2d, lower panels) to rescue the increased interac-
tion of RIP1 and FADD with caspase 8 that was observed in
knockdown cells.
Using a similar approach we next explored the ability of
various mutant forms of Pellino3 (Supplementary Fig. S3) to
re-constitute Pellino3 function in Pellino3-deficient cells in order
to define the functional relevance of its FHA and RING-like.
Forms of Pellino3s and Pellino3l, containing mutations that affect
FHA domain structure and function, failed to mimic their wild-
type counterparts in inhibiting the TNF/cycloheximide-induced
increases in annexinV staining and cleavage of PARP and caspase
3 in Pellino3 knockdown cells (Fig. 2c) and furthermore unlike
their wild-type forms they failed to inhibit complex II formation
in response to TNF (Fig. 2d). These findings indicate an
important role for the FHA domain of Pellino3 proteins in
counter-regulating the pro-apoptotic proclivity of TNF signalling.
Pellino proteins also contain a RING-like domain that is
associated with E3 ubiquitin ligase activity and we next
investigated the importance of this domain for the regulatory
effects of Pellino3 on TNF signalling. We thus mutated key
cysteine residues in the RING-like domain of Pellino3 that
abrogate the E3 ubiquitin ligase activity of wild-type Pellino3
(Supplementary Fig. S4). However, forms of Pellino3s and
Pellino3l, containing such mutations in their RING-like domain,
inhibited the ability of TNF to promote increased annexin V
staining and cleavage of PARP and caspase 3 in Pellino3
knockdown cells (Fig. 2a) and like wild-type Pellino3 they also
reduced the levels of complex II in response to TNF/cyclohex-
imide (Fig. 2b). These data suggest a dispensable role for the
RING-like domain and the E3 ligase catalytic activity of Pellino3
in manifesting its regulatory effects on TNF signalling. In
contrast, the FHA domain is of crucial importance.
Pellino3 targets RIP1 in a FHA domain-dependent manner.
Given the ability of Pellino3 to regulate TNF-induced complex II
formation, we next characterized the ability of Pellino3 to interact
with the individual protein components of complex II. We first
probed the ability of Pellino3 to interact with RIP1. The co-
expression of Pellino3s or 3l with RIP1 leads to their strong
interaction as shown by co-immunoprecipitation of Pellino3 and
RIP1 (Fig. 3a). The FHA mutants of Pellino3 showed consider-
able diminution in terms of binding to RIP1, supporting a model
where the FHA domain of Pellino3 facilitates its interaction with
RIP1. Barely detectable levels of purified RIP1 were shown to
co-immunoprecipitate with purified recombinant forms of
Pellino3s and 3l (Fig. 3b), indicating that both forms of Pellino3
can directly interact with RIP1, but with very low efficiency.
Purified forms of Pellino3 were more effective in co-precipitating
RIP1 from cell lysates (Fig. 3c), suggesting that the Pellino3/RIP1
interaction may be enhanced by some modification of RIP1 in
cells or its interaction with some ancillary protein(s). Again the
purified FHA mutants of Pellino3 were greatly diminished rela-
tive to their wild-type equivalents in their interactions with RIP1
(Fig. 3c), adding further support to a model in which Pellino3
targets RIP1 in a FHA domain-dependent manner.
Pellino3 was next assessed for its ability to interact with caspase
8, another key component of complex II. The co-expression of
procaspase 8 (with a C360A mutation to prevent autocleavage)
with Pellino3s followed by co-immunoprecipitation analysis
demonstrated that both proteins co-precipitate with each other
(Fig. 3d). Interestingly, the interaction of Pellino3 with procaspase
8 in co-expression studies is independent of the FHA domain of
the former because FHA mutants of Pellino3s and Pellino3l
mimicked their wild-type counterparts in co-immunoprecipitat-
ing with procaspase 8 (Fig. 3e). We also show that the interaction
between Pellino3 and procaspase 8 is direct in nature, as purified
recombinant forms of both proteins interact with each other
in vitro (Fig. 3f). We next characterized the regions of procaspase 8
that mediate binding to Pellino3. Procaspase 8 contains two
death effector domains (DEDa and DEDb) in its N-terminal pro-
domain and a C-terminal region that encodes for the catalytic
large (p18) and small subunits (p10). Expression constructs
encoding procaspase 8, DEDa/DEDb and caspase regions of
caspase 8 were co-expressed with Pellino3s. Co-immuno-
precipitation analysis showed that procaspase 8 and its caspase
region interacted with Pellino3, whereas there was no such
interaction between the DEDa/DEDb domain of procaspase 8 and
Pellino3 (Fig. 3d). Furthermore, the interaction of the caspase
domain with Pellino3 was proven to be direct in nature by
showing that a purified recombinant form of the caspase domain
interacts with purified Pellino3s and Pellino3l in an in vitro
binding assay (Fig. 3g). These findings thus indicate that Pellino3
can interact with RIP1 in a FHA domain-dependent manner,
whereas the latter domain is not used by Pellino3 in its direct
targeting of the caspase domain of procaspase 8. We also
generated a truncation mutant (encoding residues 1-313) of
Pellino3s, termed Pellino3sDC(1–313aa) that lacked the C-term-
inal RING-like domain and predominantly consisted of the
N-terminal FHA domain. This mutant was shown to retain the
ability of its full-length counterpart to bind to RIP1, as evidenced
by reciprocal co-immunoprecipitation of RIP1 and Pellino3sDC,
whereas it failed to interact with caspase 8 (Supplementary
Fig. S5a,b). These findings indicate that the FHA domain of
Pellino3 provides sufficient structure to physically interact with
RIP1, whereas it is fails to provide the required structure for
association with caspase 8.
We finally investigated the ability of Pellino3 to interact with
FADD, another critical constituent of complex II. However
co-expression studies failed to show an association of Pellino3
with FADD (Fig. 3h). The interaction of Pellino3 with caspase 8
was used as a positive control.
The dynamics of the interactions between endogenous Pellino3
and RIP1 and caspase 8 in response to TNF were next addressed.
Cells were treated with TNF, cycloheximide and the caspase
inhibitor ZVAD to block any RIP1 processing. RIP1 was
immunoprecipitated and assessed for co-precipitated levels of
Pellino3 and the complex II components, caspase 8 and FADD.
Using this approach TNF was shown to promote complex II
formation as evidenced by time-dependent binding of RIP1 to
caspase 8 and FADD (Fig. 4a). Interestingly, this was also
accompanied by TNF-induced association of RIP1 with both
spliced forms of Pellino3. In parallel experiments, endogenous
caspase 8 was immunoprecipitated and probed for the presence of
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co-precipitated Pellino3, RIP1 and FADD. Complex II was again
formed in response to TNF/cycloheximide, as demonstrated by
time-dependent interaction of caspase 8 with RIP1 and FADD
(Fig. 4b). Interestingly, Pellino3 was associated with caspase 8 in
unstimulated cells but the interaction was not regulated by
TNF. These studies suggest that Pellino3 basally interacts with
caspase 8 and associates with RIP1 in response to TNF
stimulation to regulate complex II formation. However, given
that RIP1 is also a part of complex I that forms in response TNF
stimulation we investigated if TNF could promote the
recruitment of Pellino3 to complex I. Hela cells were thus
stimulated with TNF alone for shorter times to study complex I
formation, after which TNFRI was immunoprecipitated and
probed for complex I components. TNF caused a time-dependent
formation of complex I as judged by the interaction of TNFRI
with RIP1 and TRAF2 (Fig. 4c). However, Pellino3 was not
recruited to TNFRI at these early times suggesting that Pellino3 is
not part of complex I in the TNF pathway. Instead TNF promotes
the binding of Pellino3 to RIP1 to counter-regulate the formation
of complex II.
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We next investigated the importance of the FHA and RING-
like domains of Pellino3 for mediating its interactions with RIP1
and caspase 8 in the context of TNF signalling. This was achieved
by expressing wild-type and mutant forms (mutated FHA and
RING-like domains) of Pellino3s and Pellino3l in HEK293 cells
and characterizing their interaction with RIP1 and caspase 8 in
response to TNF/cycloheximide stimulation. Co-immunopreci-
pitation analyses demonstrated that TNF promoted a strong and
time-dependent interaction between endogenous RIP1 and
Pellino3s (Fig. 4d; left panels) or Pellino3l (Fig. 4d; right panels).
Again both forms of Pellino3 interacted with endogenous caspase
8 in unstimulated cells and treatment with TNF failed to further
enhance this interaction (Fig. 4d). Furthermore, neither form of
Pellino3 showed association with FADD irrespective of the
absence or presence of TNF. Mutations in the FHA domain of
either form of Pellino3 abrogated the ability of the latter to
interact with RIP1, even in the presence of TNF stimulus
(Fig. 4e). Interestingly, the FHA mutants retained the capacity to
interact with caspase 8, suggesting a selective role for the FHA
domain in the targeting of RIP1. Given also the important role for
the FHA domain in facilitating the regulatory effects of Pellino3
on TNF signalling these data suggest that the targeting of RIP1 by
Pellino3 is of likely importance in its functional modulation of the
TNF pathway. In contrast, the introduction of mutations in the
RING-like domain of Pellino3s and Pellino3l failed to affect their
associations with RIP1 or caspase 8 (Fig. 4f), excluding a role for
this domain in facilitating such interactions. This is consistent
with the lack of importance of the RING-like domain in
mediating the regulatory effects of Pellino3 on TNF signalling.
We next hypothesized that the targeting of RIP1 by Pellino3
may interfere with the recruitment of RIP1 to the caspase 8/
FADD complex. In support of this hypothesis we detected greater
levels of RIP1-associated FADD in Pellino3 knockdown cells
(Supplementary Fig. S2d) and conversely overexpression of
Pellino3s significantly diminished the levels of FADD and caspase
8 that co-immunoprecipitated with RIP1 in extracts from TNF/
cycloheximide-stimulated HEK293 cells (Fig. 5). In contrast,
overexpression of a FHA mutant form of Pellino3 failed to affect
the recruitment of FADD and caspase 8 to RIP1, whereas the
RING-like domain mutant form of Pellino3s mimicked the
inhibitory effects of its wild-type counterpart (Fig. 5). These
findings further support our model that Pellino3 targets RIP1 in a
FHA domain-dependent manner, thus preventing its recruitment
of FADD and caspase 8. Interestingly, Pellino3sDC, that primarily
consists of the FHA domain and can interact with RIP1 but
not caspase 8 failed to regulate the association of FADD and
caspase 8 with RIP1 (Fig. 5), suggesting that the binding of
Pellino3 to RIP1, via its FHA domain, is required but not
sufficient to regulate the recruitment of RIP1 to the caspase
8/FADD complex.
Enhanced TNF-induced apoptosis in Pellino3-deficient cells. In
order to define the physiological relevance of the role of Pellino3
in TNF signalling, Pellino3-deficient mice were used. Mice were
generated as previously described46. Murine embryonic
fibroblasts (MEFs) from Pellino3þ /þ and Pellino3 / mice
were initially used to assess the effects of Pellino3 deficiency on
TNF signalling. Co-stimulation of MEFs with TNF and
cycloheximide caused the cells to become rounded and non-
adherent but such phenotypic changes were much more apparent
in MEFs from Pellino3 / embryos relative to their wild-type
control cells (Fig. 6a). These changes were associated with greater
levels of apoptosis as revealed by more annexin V staining
(Fig. 6b) and greater levels of cleaved PARP and caspase 3
(Fig. 6c) in cells from Pellino3 / mice. This increased apop-
totic susceptibility of Pellino3-deficient cells appears to be specific
for TNF as a death signal because MEFs from Pellino3 /
embryos do not show any enhanced sensitivity to other
pro-apoptotic pathways such as Fas (Supplementary Fig. S6a,b) or
the gentoxic compound etoposide (Supplementary Fig. S6c,d), as
measured by annexin V staining (Supplementary Fig. S6a,c) and
cleavage of PARP and caspase 3 (Supplementary Fig. S6b,d).
In order to ensure that the greater pro-apoptotic effects of TNF
in Pellino3 / cells were due specifically to Pellino3 deficiency,
Pellino3 / MEFs were re-constituted with a murine Pellino3
(mPellino3) expression construct using retroviral-mediated
transduction. High-efficiency transduction of the cells was
confirmed by microscopic detection of co-expressed GFP.
Transduction of Pellino3-deficient MEFs with retrovirus contain-
ing the murine Pellino3 gene greatly reduced the level of cell
detachment and rounding in response to TNF/cycloheximide
stimulation (Fig. 6d). Furthermore, reconstitution of Pellino3-
deficient MEFs with mPellino3 significantly reduced annexin V
staining in response to TNF/cycloheximide (Fig. 6e) and strongly
inhibited TNF-induced cleavage of PARP and caspase 3 (Fig. 6f).
The ability of mPellino3 to rescue Pellino3-deficient MEFs from
the enhanced apoptotic effects of TNF was lost when mutations
Figure 3 | Pellino3 interacts with RIP1 and caspase 8 but not FADD. (a) HEK293 cells were co-transfected with indicated constructs encoding HA-tagged
RIP1 and myc-tagged Pellino3s or Pellino3l or their corresponding FHA mutants (Pellino3s(R131A/S161A) (Pellino3sFHAm), or Pellino3l(R155A/S185A)
(Pellino3lFHAm)). Such transfections also included co-expression of the caspase inhibitor CrmA to prevent caspase-induced cleavage of RIP1 and cell
apoptosis. Cell lysates were immunoprecipitated (IP) using an anti-myc antibody followed by immunoblotting using anti-HA or -myc antibodies. Cell
lysates, prior to immunoprecipitation (input), were similarly analysed by immunoblotting. (b,c) Purified recombinant myc-tagged Pellino3s, Pellino3l or their
FHA mutant counterparts were immunoprecipitated with an anti-myc antibody and then incubated with (b) purified recombinant RIP1 protein or
(c) HEK293 cell lysates from cells previously transfected with HA-tagged RIP1. Samples were then precipitated (myc-pulldown) and analysed by
immunoblotting using anti-RIP1, -HA or -myc antibodies. Input samples represent purified RIP1 protein (b) or a cell lysate from HEK293 cells previously
transfected with HA-tagged RIP1 (c). (d) HEK293 cells were co-transfected with the indicated constructs encoding myc-tagged procaspase 8, caspase 8
DED domain (residues 1–194), caspase 8-caspase domain (residues 195–479) and flag-tagged Pellino3s. Cell lysates were immunoprecipitated (IP)
using an anti-flag antibody followed by immunoblotting (IB) using anti-myc, -flag or –bactin antibodies. Cell lysates, prior to immunoprecipitation (Input),
were similarly analysed by immunoblotting. (e) HEK293 cells were co-transfected with indicated combinations of constructs encoding HA-tagged
procaspase 8 and myc-tagged Pellino3s or Pellino3l or their corresponding FHA mutants as described above. Cell lysates were immunoprecipitated (IP)
using an anti-myc antibody followed by immunoblotting using anti-HA or -myc antibodies. Cell lysates, prior to immunoprecipitation (input), were similarly
analysed by immunoblotting. (f,g) Purified myc-tagged Pellino3s or Pellino3l was immunoprecipitated with anti-myc antibody and then incubated with
purified (f) procaspase 8 protein or (g) caspase 8-caspase domain. Samples were then precipitated (myc-pulldown) and analysed by immunoblotting using
anti-myc or –caspase 8 antibodies. Samples of recombinant Pellino proteins, procaspase 8 and caspase 8-caspase domain (Input) were similarly analysed
by immunoblotting. (h) HEK293 cells were co-transfected with constructs expressing myc-tagged Pellino3s and/or Flag-tagged FADD. Cell lysates
were immunoprecipitated (IP) using an anti-myc antibody followed by immunoblotting using anti-Flag or -myc antibodies. Cell lysates, prior to
immunoprecipitation (input), were similarly analysed by immunoblotting. Full-length images of immunoblots are shown in Supplementary Fig. S10.
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(R131A/S161A) were introduced in its FHA domain, whereas
mutations in its RING-like domain had no affect on the
regulatory effects of mPellino3 on TNF signalling (Fig. 6d–f).
These data again emphasize that loss of Pellino3 heavily biases the
TNF pathway towards activation of the caspase cascade and
ultimately apoptosis. The findings also highlight the important
role for the FHA domain besides the dispensable nature of the
RING-like domain in facilitating the ability of Pellino3 to
counter-regulate the pro-apoptotic proclivity of TNF signalling.
Given the important role of the FHA domain of Pellino3 in
targeting RIP1 and regulating the pro-apoptotic effects of TNF,
coupled to our earlier findings that the FHA domain of Pellino3
binds to RIP1 we also assessed if the FHA domain alone, of
mPellino3, was sufficient to rescue Pellino3-deficient MEFs from
the pro-apoptotic effects of TNF. However, reconstitution of
Pellino3-deficient MEFs with mPellino3sDC, which lacks the
C-terminal RING-like domain but contains the FHA domain, was
incapable of inhibiting the apoptotic effects of TNF/cyclohex-
imide, based on the lack of effect on TNF-induced cell rounding/
detachment (Supplementary Fig. S7a), annexin V staining
(Supplementary Fig. S7b) and cleavage of PARP and caspase 3
(Supplementary Fig. S7c). This is consistent with our earlier
findings demonstrating that the FHA domain of Pellino3 is not
sufficient to inhibit TNF-induced recruitment of FADD and
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caspase 8 to RIP1 (Fig. 5). Thus, while the FHA domain of
Pellino3 is critically important in targeting RIP1 and manifesting
the regulatory effects of Pellino3 on the TNF apoptotic pathway,
the FHA domain alone is not sufficient to mediate the regulatory
effects. This is consistent with a model in which the FHA domain
mediates the binding of Pellino3 to RIP1 but there resides some
additional anti-apoptotic function in Pellino3 that is lost with
truncation of its C-terminal region.
Given we hypothesize that Pellino3 regulates the pro-apoptotic
effects of TNF by targeting RIP1, we further investigated the effect
of Pellino3 deficiency in two models of TNF-induced apoptosis
that show contrasting roles for RIP1. The first model involved
cellular co-stimulation by TNF and Smac mimetics, that
antagonize cIAPs by promoting their autoubiqutination and
degradation, resulting in RIP1-dependent apoptosis33,47,48,
whereas the second model involved co-stimulation with TNF
and cycloheximide that induce apoptosis independently of the cell
death role of RIP1 (refs 33,49,50). Intriguingly, the latter studies
indicate that RIP1 has a pro-survival role under conditions of
TNF/cycloheximide co-stimulation highlighting the differential
roles of RIP1 under varying forms of TNF stimulation. We
initially demonstrated that stimulation of wild-type bone
marrow-derived macrophages (BMDMs) with TNF/Smac
mimetic triggered apoptosis as indicated by increased Annexin
V staining (Fig. 7a) and PARP/caspase 3 cleavage (Fig. 7b), and
these pro-apoptotic markers were considerably enhanced in
BMDMs from Pellino3 / mice. This was also confirmed in
human cells by demonstrating that knockdown of Pellino3
expression in Hela cells augmented TNF/Smac mimetic-induced
Annexin V staining (Fig. 7c) and PARP cleavage (Fig. 7d). Given
the critical role for RIP1 in mediating TNF/Smac-induced
apoptosis, these data are consistent with RIP1 being targeted by
Pellino3 to regulate cell apoptosis. We next characterized TNF/
cycloheximide-induced apoptosis in Pellino3-deficient cells. As
we observed earlier, the apoptotic effects of TNF/cycloheximide,
as indicated by Annexin V staining (Fig. 7e) and PARP cleavage
(Fig. 7f), were greater in Pellino3 / than wild-type MEFs. We
thus probed the role of RIP1 in mediating cell killing by TNF/
cycloheximide. Knockdown of RIP1 expression in wild type and
Pellino3-deficient MEFs strongly augmented TNF/cyclohexi-
mide-induced killing and this was inhibited by ZVAD (Fig. 7e,
f), agreeing with previous reports that RIP1 has a pro-survival
role in the TNF/cycloheximide model of apoptosis33,49,50.
Interestingly, under conditions of RIP1 knockdown, TNF/
cycloheximide induced similar levels of cell death in wild type
and Pellino3 / , suggesting that RIP1 is required to manifest
the regulatory effects of Pellino3 on TNF/cycloheximide-induced
apoptosis. Intriguingly TNF/cycloheximide caused significant
reduction in the levels of full-length RIP1 in Pellino3-deficient
MEFs (Fig. 7f, top panel) and this was coincident with the
appearance of faster migrating forms of RIP1 (second panel
Fig. 7f). This was not observed in ZVAD-treated Pellino3 /
cells, indicating that Pellino3 deficiency leads to increased
caspase-mediated cleavage of RIP1 in response to TNF/cyclohex-
imide, resulting in downregulation of the survival role of
RIP1 and increased cell death. Given that caspase 8 has previously
been reported to cleave RIP1 and promote TNF-induced
Figure 4 | TNF promotes binding of Pellino3 to RIP1 in a FHA domain-dependent manner but not as part of complex I. (a,b) Hela cells were
treated in the absence or presence of TNF (50 ngml 1) and cycloheximide (CHX) (10 mgml 1) for the indicated times. Cells were also treated with the
pan-caspase inhibitor ZVAD (20 mM) to prevent full activation of caspase 8 and cell death. Cell lysates were immunoprecipitated with anti-RIP1 (a) or anti-
caspase 8 (b) antibodies. Mouse IgG and goat IgG were used for respective control immunoprecipitations. The immunoprecipitates were subsequently
analysed for co-precipitated Pellino3, RIP1, caspase 8 and FADD by western blotting. The expression levels of Pellino3, RIP1, caspase 8 and FADD proteins
were measured in whole-cell lysates (input) by western blotting. The precipitated IgG heavy chain (IgGH) is also indicated by an arrow. (c) Hela cells were
treated in the absence or presence of TNF (50ngml 1) for indicated times. Cell lysates were immunoprecipitated with anti-TNFR1 antibody. The
immunoprecipitates were subsequently analysed for co-precipitated Pellino3, RIP1, TRAF2 and TNFR1 by western blotting. The expression levels of Pellino3,
RIP1, TRAF2 and TNFR1 proteins were measured in whole-cell lysates (input) by western blotting. (d–f) HEK293 cells were transfected with an empty
vector (EV) or expression constructs encoding (d) myc-taggged Pellino3s or Pellino3l, (e) FHA domain mutant forms of Pellino3s(R131A/S161A)
(Pellino3sFHAm) or Pellino3l(R155A/S185A) (Pellino3lFHAm) or (f) RING-like domain mutant forms of Pellino3s (C360A/C363A) (Pellino3sE3m) and
Pellino3l (C384A/C387A) (Pellino3lE3m). Cells were then treated in the absence or presence of TNF (50ngml 1) and cycloheximide (CHX) (10 mgml 1)
for indicated times. Cells were also treated with the pan-caspase inhibitor ZVAD (20 mM) to prevent full activation of caspase 8 and cell death. Cell lysates
were immunoprecipitated with an anti-myc antibody and immunoprecipitates were subsequently analysed for co-precipitated RIP1, caspase 8, FADD and
myc-tagged Pellino proteins by western blotting. The precipitated IgG light chain (IgGL) is indicated by an arrow. The expression levels of RIP1, caspase 8,
FADD and myc-tagged Pellino proteins were measured in whole-cell lysates (input) by western blotting. Full-length images of immunoblots are shown in
Supplementary Fig. S11.
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apoptosis34, these data are consistent with our hypothesis
in which Pellino3 targets RIP1 and prevents the interaction of
RIP1 with caspase 8. Conversely, Pellino3 deficiency is associated
with increased interaction of RIP1 and caspase 8, resulting in
caspase 8-mediated cleavage of RIP1 and downregulation of its
cell survival role in the TNF/cycloheximide model.
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***Po0.001; n.s: not significant (two-way ANOVA). (f) Cell lysates were probed by immunoblotting for expression levels of PARP, cleaved caspase 3,
myc-Pellino3, b-actin and GFP. Full-length images of immunoblots are shown in Supplementary Fig. S13.
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In the above model, we observed increased TNF killing in
Pellino3-deficient cells in the presence of the protein synthesis
inhibitor cycloheximide and this suggested to us that the
regulatory effects of Pellino3 on apoptosis are independent of
NFkB and its induction of anti-apoptotic proteins. To further
evaluate this possibility, we characterized the effect of Pellino3
deficiency on TNF-induced activation of NFkB and as expected
the ability of TNF to activate the NFkB and MAPK pathways in
Pellino3-deficient MEFs was intact (Fig. 8a). Indeed, the
phosphorylation of IkBa in response to TNF stimulation was
slightly more prolonged in Pellino3 / MEFs and this is
consistent with modest augmentation of TNF-induced expression
of the pro-inflammatory and NFkB-responsive gene IL-6
(Fig. 8b). Furthermore, the TNF-induced expression levels of
the anti-apoptotic genes Bcl-x (Fig. 8c), A20 (Fig. 8d) and c-FLIP
(Fig. 8e) were not reduced in Pellino3 / MEFs. These data
strongly support our earlier contention that loss of Pellino3
increases the ability of TNF to induce apoptosis by a mechanism
that involves increased interaction of RIP1 with caspase 8/FADD
and is not dependent on inhibition of NF-kB. In order to directly
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for percentage of cells staining positive for annexin V. Data represent the mean þ / s.e.m. of two independent experiments. (b,d) Cell lysates were
probed by immunoblotting using antibodies against PARP, cleaved caspase 3, pan-cIAP and b-actin. Cleaved forms of PARP and caspase 3 are indicated by
arrows. (e,f) MEFs were isolated from Pellino3þ /þ and Pellino3 / embryos and transfected with control or RIP1-specific siRNA. After 48 h, cells were
treated in the absence (control) or presence of murine TNF (40 ngml 1) plus cycloheximide (CHX) (10 mgml 1) (TC) or murine TNF plus cycloheximide
plus ZVAD (20mM) (TCZ) for 10 h. (e) Cells were analysed by flow cytometry for percentage of cells staining positive for annexin V. Data represent the
mean þ / s.e.m. of three independent experiments. **Po0.01; ***Po0.001 (two-way ANOVA). (f) Cell lysates were probed by immunoblotting for
expression levels of RIP1, cleaved PARP and b-actin. The autoradiograph for the RIP1 immunblot was exposed for short and long times. Full-length images of
immunoblots are shown in Supplementary Fig. S14.
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confirm that the regulatory effect of Pellino3 on TNF-induced
apoptosis is independent of the NFkB, a super repressor (SR)
form of the inhibitory protein IkBa (IkBaSR) was overexpressed
in wild type and Pellino3 / MEFs to block all TNF-induced
activation of NFkB (Fig. 9a). Under these conditions of NFkB
blockade, the pro-apoptotic effects of TNF were still augmented
in Pellino3 / MEFs as evidenced by enhanced Annexin V
staining (Fig. 9b) and PARP cleavage (Fig. 9c). These findings
again support our hypothesis that Pellino3 targets TNF cell killing
independently of the NFkB pathway.
To further cement this hypothesis we directly measured complex
II formation in response to TNF in Pellino3 / MEFs and also
characterized TNF-induced formation of complex I, because the
latter is a key signalling intermediate leading to downstream
activation of NFkB. Wild type and Pellino3-deficient MEFs were
thus stimulated with TNF for short times and immunoprecipitated
TNFR1 was analysed for co-precipitation of complex I components.
In wild-type MEFs, TNF promoted time-dependent recruitment of
RIP1, TRAF2, TAK1 and NEMO to TNFR1 (Fig. 10a), a classical
signature of complex I formation. The recruitment of these various
components was unaffected in Pellino3 / MEFs thus excluding a
role for Pellino3 in regulating TNF-induced formation of Complex I.
Interestingly, the formation of Complex I is facilitated by the
association of a number of these signalling proteins with
ubiquitinated RIP1 and given that our earlier findings had indicated
the targeting of RIP1 to be an important mechanism contributing to
the regulatory effects of Pellino3 on apoptosis, we investigated the
effect of Pellino3 deficiency on the ubiquitination status of RIP1.
However, TNF induced the ubiquitination of RIP1 in both wild type
and Pellino3-deficient cells with only very modest reduction in the
latter cells (Fig. 10b). This is consistent with the lack of an important
involvement for Pellino3 in regulating Complex I formation and in
downstream activation of NFkB in response to TNF. We next
characterized the effects of Pellino3 deficiency on TNF-induced
formation of complex II. Wild type and Pellino3 / MEFs were
stimulated with TNF for longer time periods and complex II was
measured by immunoprecipitation of FADD and probing for the
components RIP1 and caspase 8. In wild-type cells, TNF induced
modest interaction of RIP1 and caspase 8 with FADD but
these interactions were accelerated and strongly enhanced in
Pellino3 / MEFs (Fig. 10c). Such enhanced formation of
complex II was not restricted to MEFs from Pellino3-deficient
mice because Pellino3 / BMDMs, relative to wild-type cells,
showed greatly augmented interaction of caspase 8 and RIP1 with
FADD, in response to TNF/Smac mimetic co-stimulation
(Fig. 10d). Such increased complex II formation in Pellino3-
deficient MEFs and BMDMs correlates closely with the more
pronounced apoptotic features (described above) in response to
TNF in these Pellino3 / cells. Again these findings are
consistent with a model in which Pellino3 regulates the pro-
apoptotic tendencies of TNF by targeting RIP1/caspase 8/FADD
complex formation and not indirectly by affecting Complex I
formation or NFkB activation.
Exacerbation of TNF toxicity in Pellino3-deficient mice. The
findings above provide strong evidence for a role for Pellino3 in
regulating apoptosis in response to TNF. We next investigated the
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in vivo relevance of this role using Pellino3-deficient mice. In
order to define the in vivo role of Pellino3 in the context of the
toxic effects of TNF the well-established liver injury model was
employed in which the hepatotoxic agent D-galactosamine (D-gal)
sensitizes mice to the lethal effects of low doses of TNF. We co-
administered D-gal with sub-optimal levels of TNF that failed to
render Pellino3þ /þ mice sensitive to the lethal effects of TNF
(Fig. 11a). However, under these same conditions TNF caused
lethality in all Pellino3 / mice 24 h after administration of
TNF. The administration of D-gal alone had no affect on the
survival of Pellino3þ /þ or Pellino3 / mice. Given that
hepatoxicity is the key contributing factor to the lethal effects in
this model, liver tissue was examined from the different mouse
cohorts. We observed multifocal areas of haemorrhage in
Pellino3 / mice that had been co-administered with D-gal and
TNF, whereas no such effects were apparent in Pellino3-deficient
mice that had not been challenged with TNF or in wild-type
control mice irrespective of the administration regime (Fig. 11b).
No significant microscopic abnormalities were detected on
examination of hepatic tissue from D-gal-treated wild-type and
Pellino3-deficient mice (Fig. 11c, left panels). Co-administration
of D-gal and TNF to Pellino3þ /þ mice lead to widespread
swelling of hepatocytes due to microvesicular vacuolation and
fine granulation of the cytoplasm leading to compression of sinus
structures. This is typical of an adaptive cell response to injury
coupled with proliferation of hepatic drug-metabolizing enzymes
as a result of D-gal treatment. In contrast, the same co-admin-
istration protocol in Pellino3 / mice led to widespread hepa-
tocyte death with marked disruption of hepatocyte cord
structures and part replacement by red blood cells. Individual
hepatocytes were swollen with many cells containing karyor-
rhectic (fragmented) nuclei. The hepatocyte death observed in the
latter group was apoptotic in nature because immunhistochemical
analysis of the hepatic tissue clearly showed intense immunor-
eactivity with an anti-cleaved caspase 3 antibody (Fig. 11c, right
panels). This was further confirmed by western blot analysis
demonstrating very high levels of cleaved caspase 3 and caspase 8
in hepatic tissue from Pellino3 / mice that had been chal-
lenged with D-gal and TNF (Fig. 11d). These data provide very
strong evidence for a critical physiological role for Pellino3 in
regulating the potential toxic effects of TNF. Furthermore, the
severe hepatotoxicity observed in the Pellino3 / mice reflects a
role for Pellino3 in directly regulating the apoptotic process
rather than modulating a systemic inflammatory response,
because lack of Pellino3 fails to affect circulating serum levels of
IL-6, IL-10 or TNF (Fig. 11e). In conjunction with the earlier cell-
based approaches these in vivo findings provide strong support
for Pellino3 acting as a novel factor in TNF biology. The high
sensitivity of Pellino3 / mice to the lethal effects of TNF
strongly promotes Pellino3 as a crucial factor in determining
whether cells survive or die in response to TNF challenge.
Discussion
This study highlights a critical role for Pellino3 in regulating the
pro-apoptotic effects of TNF. The initial suggestion of such a role
arose from our human cell line studies in which Pellino3
knockdown augmented the apoptotic effects of TNF. This
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regulatory role for Pellino3 was observed in a number of cell types
indicating an important function for Pellino3 in various TNF-
responsive cells. The physiological relevance of Pellino3 in the
TNF pathway was confirmed by the generation of Pellino3-
deficient mice with cells from these mice displaying increased
sensitivity to the pro-apoptotic effects of TNF. Furthermore
Pellino3-deficient mice showed greatly increased susceptibility to
the lethal effects of TNF and this was associated with increased
severity of TNF-induced hepatotoxicity. All of these findings
strongly promote Pellino3 as a regulator of the apoptotic pathway
that is triggered by TNF and provides the first data showing that a
member of the Pellino family can regulate TNF signalling.
Given that NF-kB acts to counter-regulate the apoptotic
pathway by the induction of anti-apoptotic proteins, it was of
interest to examine whether Pellino3 could exert its regulatory
effects on TNF-induced apoptosis by affecting the NF-kB
pathway. However, the increased apoptosis that is observed in
Pellino3 knockdown or -deficient cells cannot be easily explained
by the regulation of NF-kB, because we observed increased TNF
killing in Pellino3-deficient cells in the presence of the protein
synthesis inhibitor cycloheximide, and the augmented pro-
apoptotic effects of TNF, under conditions of Pellino3 deficiency,
are still observed when the NFkB pathway is blocked by IkBaSR.
Furthermore, cells lacking Pellino3 do not show any deficit in the
activation of the NF-kB in response to TNF. Indeed, there
appears to be a modest augmentation of the NF-kB pathway in
such cells in response to TNF, suggesting that Pellino3 may exert
some negative influence on NF-kB. This is consistent with a
previous report indicating that Pellino3 may negatively regulate
IL-1-induced activation of NF-kB51. Furthermore, Peli1 has been
recently shown to inhibit T cell activation by downregulating the
NF-kB subunit c-Rel52, indicating that the Pellino family may
serve important roles in controlling the activation of NF-kB.
Given that the targeting of the NF-kB pathway by Pellino3
does not provide an underlying basis to its regulatory effects on
apoptosis, we probed a direct role for Pellino3 in the apoptotic
pathway. Our findings demonstrate that Pellino3 has an
important role in controlling complex II formation in response
to TNF. We show that Pellino3 can interact with the complex II
components, caspase 8 and RIP1, with the latter interaction being
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driven by TNF. Indeed, the targeting of RIP1 by Pellino3 appears
to be important in mediating the regulatory effects of Pellino3 on
TNF-induced apoptosis because mutants of Pellino3 that lack the
ability to interact with RIP1, while still associating with caspase 8,
fail to regulate complex II formation or progression to apoptosis
in response to TNF. It is especially intriguing that the targeting of
RIP1 by Pellino3 is a key part of the regulatory process given the
pivotal role of RIP1 in determining cell fate in response to TNF
challenge. The ubiquitination of RIP1 by E3 ligases, such as the
IAPs, has traditionally been associated with promoting formation
of Complex I and activation of the NF-kB pathway and blocking
complex II formation by inhibiting the binding of RIP1 to FADD
and caspase 8 (ref. 16). We thus considered the possibility that the
negative regulatory effects of Pellino3 on complex II formation
may be explained by Pellino3-induced ubiquitination of RIP1.
However, in Pellino3-deficient cells we were unable to detect any
major reduction in the ubiquitination of RIP1 in response to TNF
and this is consistent with the lack of effect of Pellino3 deficiency
on TNF-induced formation of Complex I and activation of NFkB.
Furthermore, we show that the regulatory effects of Pellino3 on
complex II formation and apoptosis are independent of its RING-
like domain. This suggests that Pellino3 contains important
regulatory functions independent of its E3 catalytic activity.
Instead, the FHA domain of Pellino3 is crucially important in
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facilitating its regulatory effects on the pro-apoptotic effects of
TNF. To date, the FHA domain of the Pellino family has been
associated with mediating binding to the IRAK family members40
but the present data identifies RIP1 as a key target for Pellino3,
with the FHA domain of the latter being a key requirement for
associating with RIP1. While the FHA domain has a critical role
in mediating the regulatory effects of Pellino3, the C-terminal
region of the protein is also required to manifest regulatory
activity and this may reflect a need for Pellino3 to interact with
caspase 8 because the FHA domain of Pellino3, which lacks the
C-terminal region of the full-length protein, is unable to bind to
caspase 8. Indeed, it will be interesting for future studies to
explore the potential of Pellino3 to inhibit the activity of caspase 8
and/or access of the latter to its substrates, as this may also
contribute to the regulatory effects of Pellino3 on TNF-induced
apoptosis.
The FHA domain is a phosphothreonine-binding module and
the identification of potential recognition sites on RIP1 for the
FHA domain of Pellino3 will add greatly to our understanding of
this pathway. Indeed, it is interesting to note that while Pellino3
can interact directly with RIP1 in an in vitro setting, this is barely
detectable and strong binding of RIP1 to Pellino3 is only
manifested in a cell setting and in response to TNF stimulation.
Thus TNF may induce the phosphorylation of RIP1 allowing for
high-affinity recognition of RIP1 by the FHA domain of Pellino3.
Indeed, our findings are consistent with a model where stimulation
of cells with TNF promotes binding of Pellino3, via its FHA
domain, to RIP1 and this inhibits the binding of FADD to RIP1.
This will lead to reduced interaction of RIP1 and caspase 8 and so
reduces the likelihood of triggering the apoptotic pathway. In a
situation where Pellino3 is absent, this braking mechanism no
longer applies, leading to increased complex II formation and
apoptosis in response to TNF, even under circumstances where
NF-kB activation has not been compromised.
Our hypothesis that Pellino3 targets RIP1 as part of mediating
its regulatory effects in the TNF pathway also serves to explain
the apparent contrasting roles of RIP1 in TNF/Smac- and TNF/
cycloheximide-induced apoptosis. The Smac mimetic mimics the
activity of the mitochondrial protein Smac/Diablo by inhibiting
IAP proteins and promoting autoubiquitination and degradation
of cIAP1 and cIAP2, leading to loss of RIP1 ubiquitination and
formation of complex II and RIP1-mediated downstream
triggering of apoptosis47,48,53–57. In the TNF/Smac mimetic
model, we show that Pellino3 negatively regulates the recruitment
of RIP1 to Complex II and so represses the pro-death role of RIP1
in this model. In contrast, we confirm previous reports that cell
killing by TNF/cycloheximide is not mediated by RIP1 and
instead RIP1 has a survival role under these conditions33,49,50. In
this TNF/cycloheximide model, Pellino3 positively regulates the
pro-survival role of RIP1 by limiting interaction of the latter with
caspase 8 and so preventing caspase 8-induced cleavage of RIP1
and facilitating RIP1-mediated cell survival. The mechanism
underlying such a survival role of RIP1 is not understood but
studies to investigate the potential of RIP1 to decrease caspase
activity in Complex II under these conditions may be informative.
Furthermore, as Pellino3 also interacts with caspase 8 it is
interesting to speculate that Pellino3 may work in conjunction
with RIP1 to regulate the activity of caspase 8.
We were also keen to explore if the regulatory effects of
Pellino3 on the formation of a complex containing FADD, RIP1
and caspase 8 extended beyond pathways that are triggered by
TNFR1. Intriguingly the effects of Pellino3 appear to show a high
degree of specificity towards the TNF pathway, as we show that
the pro-apoptotic effects of the related Fas pathway are not
subject to regulation by Pellino3. Furthermore, two recent reports
have characterized a death-inducing cytosolic complex containing
FADD, RIP1 and caspase 8 that forms independently of death
receptor activation but in response to intracellular stress58,59.
These latter studies describe the formation of a complex termed
the ‘Ripoptosome’ that contains FADD, RIP1 and caspase 8 and
forms spontaneously in response to the depletion of cIAPs by IAP
antagonists or the genotoxic compound etoposide. We explored
the potential of Pellino3 to regulate the cell death pathways
induced by etoposide, in MEFs, but like the Fas pathway, Pellino3
was without effect. However, our data does not fully exclude a
potential role for Pellino3 in regulating etoposide-induced cell
death in other cell types, especially cancer cells, given that
etoposide has been shown to promote the interaction of RIP1
with caspase 8 in tumour but not normal cells48. Furthermore,
while the mechanistic basis to the specificity of Pellino3 for the
TNF pathway is unknown it may reside in Pellino3 targeting a
unique component of the TNF signal transduction system or
alternatively TNF may be unique in regulating or modifying
Pellino3 to a state in which it can manifest its regulatory
potential.
The targeting of RIP1 by Pellino3 is of interest to Pellino
biology given that Peli 1 has also been demonstrated to target
RIP1 (ref. 37). However, the outcomes of such interactions differ
at the functional and molecular levels. First, while Pellino3
targets RIP1 to regulate cell killing, Pellino1 interacts with RIP1
to promote activation of NF-kB, at least in the context of TLR3
and TLR4 signalling37. Second, while the interaction of Pellino3
with RIP1 and its regulatory effects on apoptosis are independent
of its RING-like domain, Pellino1 is proposed to facilitate
activation of the NF-kB pathway by catalysing polyubiquitination
of RIP1 (ref. 37). Such varying roles for these members of the
Pellino family is not without precedent because Pellino3
negatively regulates IL-1-induced activation of NFkB51, whereas
Pellino1 acts as a positive regulator of IL-1 signalling44, although
the latter suggestion has recently been challenged with findings
from Pellino1-deficient mice37. It will be of great interest to
explore the potential interplay between Pellino1 and Pellino3 in
terms of regulating RIP function in the TNF pathway. While cell
line studies suggest that Pellino1 is not involved in TNF
signalling44 the recent generation of Pellino1 knockout mice
will allow for examination of its role in a more physiological
setting.
In summary the present findings highlight Pellino3 as a new
factor in the TNF signalling pathway and indicate that it may
have an important role in determining whether a cell survives or
dies in response to TNF. The present study also adds to a growing
appreciation of the diverse functions of the Pellino family in
immune signalling pathways. While most studies to date have
focused on Pellino proteins as regulators of IL-1 and TLR
signalling, the present report extends their roles beyond these
pathways. Furthermore, Peli1 has been described as an important
regulator of T-cell activation and self tolerance52,60. Such
findings, in conjunction with the present report, add to an
increasing appreciation of the importance of the Pellino family in
a variety of signalling pathways in the innate and adaptive
immune systems.
Methods
Pellino3-deficient mice. Pellino3-deficient mice were generated by Taconic
Artemis using its proprietary technology as previously described46. Briefly, a
targeting vector, in which exon 3 of the Pellino3 gene was flanked by loxP sites, was
designed to generate homologous recombinant ES clones that were used to
generate chimeric mice. To make constitutive Pellino3 / mice, mice that were
heterozygous for the targeted allele were bred with mice containing Cre
recombinase regulated by the ROSA26 locus (C57BL/6 Gt(ROSA)26Sortm16
(Cre)Arte). This results in the deletion of exon 3 and loss of function of the Pellino3
gene by generating a frameshift in all downstream exons. The Cre transgene was
subsequently removed by breeding the Pellino3þ / mice with C57BL/6 mice
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during colony expansion. Animal breeding and maintenance were performed in the
Bioresource facility of National University of Ireland (NUI) Maynooth. All animal
experiments were performed in accordance with protocols approved by the
Research Ethics committee of NUI Maynooth. Eight-week-old male mice were used
for in vivo studies.
Cell culture. Hela, HEK293 and 1321N1 cells were cultured in Dulbecco’s mod-
ified Eagle’s medium supplemented with 10% (v/v) fetal bovine serum (FBS),
100mgml 1 penicillin G and 100 mgml 1 streptomycin. Cells were maintained at
37 C in a humidified atmosphere of 5% CO2. For the preparation of primary
MEFs, Pellino3þ / mice were bred to generate Pellino3þ /þ and Pellino3 /
embryos. Embryos were dissected from pregnant females at day 13 post coitum.
MEFs were isolated by standard procedure and cultured in DMEM supplemented
with 10% (v/v) FBS. Immortalized WT and Peli3 / BMDMs were kindly pre-
pared by Dr Kate Fitzgerald (The University of Massachusetts Medical School,
Worcester, Massachusetts, USA) and cultured in Dulbecco’s modified Eagle’s
medium supplemented with 10% (v/v) FBS, 100 mgml 1 penicillin G and
100mgml 1 streptomycin.
Expression vectors. The plasmids pcDNA3.1-Pellino3s-/3l-myc, Pellino3s(R131A/
S161A)-myc (Pellino3sFHAm), Pellino3l(R155A/S185A)-myc (Pellino3lFHAm),
Pellino3s(C360A/C363A)-myc (Pellino3sE3m) and Pellino3l (C384A/C387A)-myc
(Pellino3lE3m), flag-Pellino3sDC(1-313aa) and HA-caspase 8 (C360/A) were gen-
erated in-house. Pellino3s-flag was from Xiaoxia Li (Cleveland Clinic). Myc-RIP1
was from Xin Lin (University of Texas, M.D. Anderson Cancer Center). HA-RIP1
and CrmA were from JinWoo Kim (Korea Advanced Institute of Science and
Technology). Caspase 8 (C360/A)-myc and flag-FADD were from A. Thorburn
(University of Colorado at Denver and Health Sciences Center). IkBaSR was from
Dr Martina Schro¨der (National University of Ireland, Maynooth, Ireland). Trun-
cation mutants encoding the DED (1-194aa) and caspase (195–479aa) domains of
caspase 8 were cloned into pcDNA4.0 vector. Myc-tagged Pellino3s, Pellino3l,
Pellino3sFHAm and Pellino3lFHAm were subcloned into His-tagged pRSET-A
(Invitrogen). Procaspase 8 and the caspase domain (195–479aa) of caspase 8 were
cloned into the His-tagged vector pET-30a (Novagen). MPellino3 was cloned from
embryo brain and into the retroviral MSCV2.2-IRES-GFP vector. FHA (R131A/
S161A) (mP3Fm), RING-like domain (C360A/C363A) (mP3Em) and DC(1–313aa)
mutants of mPellino were generated in house.
Antibodies and reagents. Anti-RIP1 (610459 BD) (1:1,000 working dilution) was
from BD Transduction Labs; anti-caspase 8 (C-20; sc-6136) (for immunoprecipi-
tations) (1:1,000), anti-IkBa (C-21; sc-371) (1:1,000), anti-TRAF2 (C-20; sc-876)
(1:500), anti-TNFR1 (H-5; sc-8436) (1:500), anti-Tak1 (M-579; sc-7162) (1:500),
anti-NEMO (FL-419; sc-8330) (1:500) and anti-Ub (P4D1; sc-8017) (1:500) were
from Santa Cruz; anti-HA (2367) (1:1,000), anti-Myc (2276) (1:2,000), anti-PARP
(9542) (1:2,000), anti-cleaved caspase 3 (9664) (1:500), anti-caspase 8 (9746)
(1:500), anti-p-IkBa (9246) (1:500), anti-JNK(9252) (1:1,000), anti-P38 (9212)
(1:1,000), anti-Erk (9102) (1:2,000), anti-p-JNK (9251) (1:1,000), anti-p-ERK
(9101) (1:1,000), and anti-p-P38 (9211) (1:1,000) were from Cell Signaling; anti-
caspase 8 (mouse) (1G12; ALX-804-447) (1:1,000) and anti-FADD (1F7; AAM-
212) (1:1,000) were from Enzo Life Science; anti-human and mouse TNFR1
(AF225; AF-425-PB) (for immunoprecipitations) (1:1,000) and anti-human and
mouse Pan-cIAP (MAB3400) (1:1,000) were from R&D Systems; anti-b-actin (AC-
15; A 1978) (1:10,000) was from Sigma; anti-Pellino3 antibodies (1:1,000) were
generated in-house; anti-mouse IRDyeTM 700 (1:5,000), anti-rabbit IRDyeTM 800
(1:5,000) and anti-rabbit IRDyeTM 700 light chain (1:5,000) were from LI-COR
Biosciences; anti-goat IRDyeCW800 (1:10,000) was from Rockland; anti-mouse-
HRP (1:5,000) was from Cell Signaling; anti-rabbit-HRP (1:5,000) was from
Promega; anti-Goat-HRP (1:5,000) was from Santa Cruz; TNFa was from R&D
Systems; anti-Fas (554255) was from BD Pharmingen; Etoposide (E1383) and
Cycloheximide (C4859) were from Sigma; ZVAD-FMK (G7232) was from
Promega. SMAC peptide was a gift from Professor Luke O’Neill (Trinity College
Dublin, Ireland). BV6 was a gift from Professor Harald Wajant (University Hos-
pital Wu¨rzburg, Germany).
Preparation and transfection of siRNA. Human Pellino3-specific siRNA (sense:
50-GCACAGCAUCUCGUAUACATT-30 ; antisense: 50-UGUAUACGAGAUGCU
GUGCTG3-30) and murine RIP1-specific siRNA (sense: 50-GGUGGUACCCUUU
ACUACATT-30 ; antisense: 50-UGUAGUAAAGGGUACCACCAT-30) were from
Ambion. Cells were transfected by Lipofectamine 2000 according to the manu-
facturer’s instructions and allowed to recover for 48 h prior to experiments.
Pellino3 knockdown by lentiviral shRNA in human cells. Lentiviral constructs
encoding human Pellino3 shRNA were purchased from Sigma. The shRNA
sequence specifically targeted the 30 UTR of Pellino3 and had the following
sequence: GCACTTGCTGATAGCCACTATCCGGGCACTTGCTGATAGCCA
CTATCTCGAGATAGTGGCTATCAGCAAGTGCTTTTTTG.
Constructs were co-transfected with packaging and envelope plasmids (dR89.1
and VSV-G) into 293T cells, and lentivirus from the medium supernatants was
used to infect Hela, HEK293 and 1321N1 cells. Cells were subsequently grown
for 1 week under puromycin (10mgml 1) selection. The knockdown efficiency
was assessed by the immunoblotting of whole-cell lysates. Control cells were
infected with lentivirus containing a nontargeting shRNA vector that encodes for
shRNA that does not match any known human or mouse gene. For rescue assays,
expression constructs encoding myc-tagged wild type or mutated forms of Pellino3
were transfected into puromycin-selected cells. Cells were then assessed for various
features associated with apoptosis.
Real-time PCR assays. Real-time PCR analyses were performed using TaqMan
Gene Expression kits (Finnzymes), according to the manufacturer’s instructions.
The following primers were used to amplify the fragments of the indicated genes:
mA20, forward, 50-TGCCAGTTTTGCCCACAGT-30 and reverse, 50-TTCAGAG
CCACGAGCTTCCT-30 ; mcFlip, forward, 50-GCTCCAGAATGGGCGAAGT-30
and reverse, 50-CACGGATGTGCGGAGGTAA-30 . Each mRNA quantification was
normalized relative to the housekeeping gene hypoxanthine phosphoribosyl-
transferase 1 (HPRT) using the primers; mHPRT forward, 50-GTCCCAGCGTCGT
GATTAGC-30 and reverse, 50-TGGCCTCCCATCTCCTTCA-30 .
Immunoprecipitation and western blot analysis. Cells were grown in six-well
plates and then transfected with designated expression constructs. For TNFR1-
associated complex I analysis, cells were stimulated for various times with TNFa
(50 ngml 1). For DISC complex II analysis, cells were stimulated for various times
with TNFa (40 ngml 1), cycloheximide (10mgml 1) and ZVAD-FMK (20 mm).
Cells were subsequently harvested in 500 ml of lysis buffer (20mM Tris–HCl (pH
7.4), containing 150mM NaCl, 0.2% (v/v) Igepal, 10% (w/v) Glycerol, 50mM NaF,
1mM Na3VO4, 1mM phenylmethylsulfonyl fluoride and complete protease inhi-
bitor cocktail (Roche)) and incubated at 4 C for 30min with gentle rocking. Cell
lysates were centrifuged at 14,000 g for 10min to remove cell debris and nuclei. An
aliquot (50 ml) of the supernatant was retained for western blot analysis, and the
remainder was subjected to immunoprecipitation. Cell lysates were initially pre-
cleared by incubating with non immune IgG antibody (1 mg) and protein A/G
agarose (10 ml) for 1 h at 4 C with rocking followed by rapid centrifugation of the
agarose beads. Each supernatant was removed to a fresh microcentrifuge tube
followed by addition of the appropriate antibody (2 mg) and incubated for 24 h at
4 C with rocking. An aliquot (50 ml) of protein A/G agarose was added to each
sample and incubated with rocking overnight at 4 C. Immunoprecipitates were
collected by passing the samples through Cytosignal filters by centrifugation at
16,000 g for 1min at 4 C. The trapped beads were then washed four times with
500 ml of lysis buffer (without Na3VO4, dithiothreitol, phenylmethylsulfonyl
fluoride or protease inhibitor cocktail). An aliquot (60 ml) of SDS–PAGE sample
buffer was added to the trapped beads and the immunoprecipitated proteins were
eluted by centrifugation at 16,000 g for 1min. Samples were boiled for 5min,
resolved by SDS–PAGE, transferred to nitrocellulose membranes and analysed by
immunoblotting using the appropriate antibodies. Immunoreactivity was visualized
by the Odyssey Imaging System (LI-COR Biosciences) or enhanced
chemiluminescence.
Generation of recombinant proteins and in vitro binding assays. Myc-tagged
Pellino3s, Pellino3l, Pellino3sFHAm and Pellino3lFHAm were cloned into the His-
tagged vector pRSET-A (Invitrogen). Procaspase 8, the caspase domain
(195–479aa) of caspase 8 and RIP1 were cloned into the His-tagged vector pET-30a
(Novagen). The constructs were transformed into Escherichia coli cells, protein
expression induced by IPTG and recombinant proteins purified from cell lysates by
affinity chromatography using nickel–nitrilotriacetic acid–agarose (Qiagen)
according to the manufacturer’s instructions. The purity and integrity of recom-
binant proteins were confirmed by subjecting samples to SDS–PAGE (followed by
Coomassie staining) in addition to western blotting using the appropriate anti-
bodies. For the in vitro binding assays characterizing the binding of Pellino3 to
partner proteins, recombinant myc-tagged Pellino3 proteins (1 mg) were initially
immunoprecipitated in binding buffer (20mM Tris–HCl (pH 7.4), containing
150mM NaCl, 0.2% (v/v) Igepal, 10% (w/v) glycerol and complete protease inhi-
bitor cocktail) using an anti-myc antibody (2mg) and protein A/G beads (30 ml) as
above. The beads were washed five times with binding buffer and then incubated
overnight at 4 C with purified recombinant forms of procaspase 8 or its caspase
domain (300 ng) or recombinant RIP1(200 ng) or lysates (300 ml per well of six-well
plates) from HEK293 cells previously transfected with HA-tagged RIP1. Beads were
subjected to serial washes with binding buffer followed by centrifugation. Co-
precipitated proteins were eluted in SDS–PAGE sample buffer and then subjected
to western blot analysis.
In Vitro K63 ubiquitination assay. Recombinant Pellino3s, P3sFHAm or P3sE3m
protein (0.5 mg) were incubated with ubiquitin (with all lysine residues, except
residue 63, mutated to arginine (K63 only) (2mg), E1 (50 ng), UbcH13 (400 ng) and
protease inhibitor mixture (EDTA-free) in 5mM Tris-HCl (pH 7.5) containing
2mMMgCl2, 2mM ATP and 100mM NaCl. Reactions were incubated at 37 C for
2 h and terminated by the addition of SDS–PAGE sample buffer. Samples were
boiled for 5min, resolved by SDS–PAGE, transferred to nitrocellulose membranes
and analysed by immunoblotting using an anti-ubiquitin antibody.
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FACS. Wild type and Pellino3 knockdown or knockout cells were treated as
indicated and assayed for programmed cell death using an Annexin V-FITC
Apoptosis Detection Kit (BD Pharmingen) according to the manufacturer’s
instructions. Briefly, cells were washed once in PBS and then in binding buffer
(10mM Hepes (pH 7.4), containing 140mM NaCl and 2.5mM CaCl2). Washed
cells were resuspended in binding buffer (1–5 106 cells per ml) and aliquots
(100 ml) of resuspended cells were incubated for 15min at room temperature in the
dark with Annexin V-FITC (5ml). Binding buffer (400 ml) was added to each
sample followed by flow cytometric analysis of Annexin V-reactive cells using a
FACSCalibur flow cytometer and CellQuest software (BD Biosciences).
MTT assays. Control and Pellino3 knockdown cells were grown in 48-well plates
and then stimulated with TNFa (40 ngml 1) and cycloheximide (10 mgml 1) or
cycloheximide alone for indicated times. 3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphe-
nyltetrazolium bromide (MTT) (5mgml 1) was added to the cells and incubated
for 3 h at 37 C. Media was removed and DMSO added to solubilize the cells. The
absorbance of the solubilized material was measured at 540 nm using a BioTEK
Microplate Reader and this was used as an index of mitochondrial activity and thus
cell viability.
Retroviral rescue assay. MSCV plasmid or MSCV-mPellino3 (mP3), MSCV-
mP3Fm and MSCV-mP3Em or MSCV-mP3DC (1mg) were co-transfected with the
packaging vector c (1 mg) into 293T cells. After 48 h, the retrovirus-containing
medium was harvested and used to infect Pellino3-deficient MEFs in 25-cm2 flasks.
The flasks were incubated at 37 C for 48 h prior to experiments.
In vivo toxicity studies involving TNF and D-galactosamine. Age- and sex-
matched wild-type and Pellino3-deficient mice were injected intraperitoneally with
TNF (0.0025 mg g 1 body weight) plus D-galactosamine (0.8mg g 1 body weight).
Mouse survival was monitored over a time period of 36 h. In some experiments
mice were killed 12 h after injection, liver samples collected and processed for
immunohistochemical analysis. In other cases serum samples were obtained 7 h
after injection and assayed for levels of IL-6, IL-10 and TNF using sandwich ELISA
kits according to the manufacturer’s instructions (R&D Systems).
Immunohistochemical analysis. At post-mortem examination samples of liver
tissue were fixed in neutral buffered formalin. Following fixation tissues were
paraffin-embedded, sectioned at 5 mm and stained with haematoxylin and eosin
(H&E). For detection of cleaved caspase 3, sections were initially deparaffinized
and incubated in 0.3% (v/v) H2O2 (Fluka) for 30min for blockade of endogenous
peroxidase activity. Sections were blocked with PBS containing 5% (v/v) goat serum
(Vector) and then incubated with anti-cleaved caspase 3 antibody (9664; Cell
Signalling). The Vectastain ABC kit (PK-6100; Vector Laboratories) was used
according to the manufacturer’s specifications for detection of immunoreactivity.
Peroxidase activity was visualized with ImmPACT DAB (Brown). Hematoxylin
(blue) was used as the nuclear counterstain. Staining was viewed with an E-800
Eclipse microscope (Nikon).
TUNEL staining and confocal microscopy. Cells were treated as indicated and
then fixed in 4% (w/v) paraformaldehyde for 15min. Fixed cells were stained
using the DeadEnd Fluorometric TUNEL System (Promega) and Hoechst 33342
(Sigma) according to the manufacturer’s instructions. Confocal images were
captured using the  40 objective on the Olympus Fluoview System laser scanning
microscope equipped with the appropriate filter sets and analysed using Photoshop
8.0 and SPOT 3.5 software.
Statistical analysis. Student’s t-test and two-way ANOVA were used, where
appropriate, for statistical analysis.
References
1. Varfolomeev, E. E. & Ashkenazi, A. Tumor necrosis factor: an apoptosis
JuNKie? Cell 116, 491–497 (2004).
2. Hsu, H., Xiong, J. & Goeddel, D. V. The TNF receptor 1-associated
protein TRADD signals cell death and NF-k B activation. Cell 81, 495–504
(1995).
3. Karin, M. & Gallagher, E. TNFR signaling: ubiquitin-conjugated TRAFfic
signals control stop-and-go for MAPK signaling complexes. Immunol. Rev.
228, 225–240 (2009).
4. Wilson, N. S., Dixit, V. & Ashkenazi, A. Death receptor signal transducers:
nodes of coordination in immune signaling networks. Nat. Immunol. 10, 348–
355 (2009).
5. Ashkenazi, A. & Dixit, V. M. Death receptors: signaling and modulation.
Science 281, 1305–1308 (1998).
6. Chen, G. & Goeddel, D. V. TNF-R1 signaling: a beautiful pathway. Science 296,
1634–1635 (2002).
7. Wallach, D. et al. Tumor necrosis factor receptor and Fas signaling
mechanisms. Annu. Rev. Immunol. 17, 331–367 (1999).
8. Micheau, O. & Tschopp, J. Induction of TNF receptor I-mediated apoptosis via
two sequential signaling complexes. Cell 114, 181–190 (2003).
9. Muppidi, J. R., Tschopp, J. & Siegel, R. M. Life and death decisions: secondary
complexes and lipid rafts in TNF receptor family signal transduction. Immunity
21, 461–465 (2004).
10. Karin, M. Nuclear factor-kB in cancer development and progression. Nature
441, 431–436 (2006).
11. Wertz, I. E. et al. De-ubiquitination and ubiquitin ligase domains of A20
downregulate NF-kappaB signalling. Nature 430, 694–699 (2004).
12. Lee, T. H., Shank, J., Cusson, N. & Kelliher, M. A. The kinase activity of Rip1 is
not required for tumor necrosis factor-a-induced IkB kinase or p38 MAP
kinase activation or for the ubiquitination of Rip1 by Traf2. J Biol Chem 279,
33185–33191 (2004).
13. Alvarez, S. E. et al. Sphingosine-1-phosphate is a missing cofactor for the E3
ubiquitin ligase TRAF2. Nature 465, 1084–1088 (2010).
14. Yamamoto, M. et al. Key function for the Ubc13 E2 ubiquitin-conjugating
enzyme in immune receptor signaling. Nat. Immunol. 7, 962–970 (2006).
15. Varfolomeev, E. et al. c-IAP1 and c-IAP2 are critical mediators of tumor
necrosis factor alpha (TNFa)-induced NF-kB activation. J. Biol. Chem. 283,
24295–24299 (2008).
16. Bertrand, M. J. et al. cIAP1 and cIAP2 facilitate cancer cell survival by
functioning as E3 ligases that promote RIP1 ubiquitination. Mol. Cell 30,
689–700 (2008).
17. Mahoney, D. J. et al. Both cIAP1 and cIAP2 regulate TNFa-mediated NF-kB
activation. Proc. Natl Acad. Sci. USA 105, 11778–11783 (2008).
18. DiDonato, J. A., Hayakawa, M., Rothwarf, D. M., Zandi, E. & Karin, M. A
cytokine-responsive IkB kinase that activates the transcription factor NF-kB.
Nature 388, 548–554 (1997).
19. Mercurio, F. et al. IKK-1 and IKK-2: cytokine-activated IkappaB kinases
essential for NF-kappaB activation. Science 278, 860–866 (1997).
20. Regnier, C. H. et al. Identification and characterization of an IkappaB kinase.
Cell 90, 373–383 (1997).
21. Ea, C. K., Deng, L., Xia, Z. P., Pineda, G. & Chen, Z. J. Activation of IKK by
TNFalpha requires site-specific ubiquitination of RIP1 and polyubiquitin
binding by NEMO. Mol. Cell 22, 245–257 (2006).
22. Meylan, E. & Tschopp, J. The RIP kinases: crucial integrators of cellular stress.
Trends Biochem. Sci. 30, 151–159 (2005).
23. Ting, A. T., Pimentel-Muinos, F. X. & Seed, B. RIP mediates tumor necrosis
factor receptor 1 activation of NF-kB but not Fas/APO-1-initiated apoptosis.
EMBO J. 15, 6189–6196 (1996).
24. Ishitani, T. et al. Role of the TAB2-related protein TAB3 in IL-1 and TNF
signaling. EMBO J. 22, 6277–6288 (2003).
25. Wang, C. et al. TAK1 is a ubiquitin-dependent kinase of MKK and IKK. Nature
412, 346–351 (2001).
26. Chen, Z. J. Ubiquitin signalling in the NF-kappaB pathway. Nat. Cell Biol. 7,
758–765 (2005).
27. Chu, Z. L. et al. Suppression of tumour necrosis factor-induced cell death by
inhibitor of apoptosis c-IAP2 is under NF-kB control. Proc. Natl Acad. Sci. USA
94, 10057–10062 (1997).
28. Kreuz, S., Siegmund, D., Scheurich, P. & Wajant, H. NF-kappaB inducers
upregulate cFLIP, a cycloheximide-sensitive inhibitor of death receptor
signalling. Mol. Cell Biol. 21, 3964–3973 (2001).
29. Wang, C. Y., Mayo, M. W., Korneluk, R. G., Goeddel, D. V. & Baldwin, Jr. A. S.
NF-kappaB antiapoptosis: induction of TRAF1 and TRAF2 and c-IAP1
and c-IAP2 to suppress caspase-8 activation. Science 281, 1680–1683
(1998).
30. Declercq, W., Vanden Berghe, T. & Vandenabeele, P. RIP kinases at the
crossroads of cell death and survival. Cell 138, 229–232 (2009).
31. Zhang, S. Q., Kovalenko, A., Cantarella, G. & Wallach, D. Recruitment
of the IKK signalosome to the p55 TNF receptor: RIP and A20 bind to
NEMO (IKKgamma) upon receptor stimulation. Immunity 12, 301–311
(2000).
32. O’Donnell, M. A., Legarda-Addison, D., Skountzos, P., Yeh, W. C. & Ting, A. T.
Ubiquitination of RIP1 regulates an NF-kB-independent cell-death switch in
TNF signalling. Curr. Biol. 17, 418–424 (2007).
33. Wang, L., Du, F. & Wang, X. TNF-alpha induces two distinct caspase-8
activation pathways. Cell 133, 693–703 (2008).
34. Lin, Y., Devin, A., Rodriguez, Y. & Liu, Z. G. Cleavage of the death domain
kinase RIP by caspase-8 prompts TNF-induced apoptosis. Genes Dev. 13,
2514–2526 (1999).
35. Cusson-Hermance, N., Khurana, S., Lee, T. H., Fitzgerald, K. A. & Kelliher, M.
A. Rip1 mediates the Trif-dependent toll-like receptor 3- and 4-induced
NF-{k}B activation but does not contribute to interferon regulatory factor 3
activation. J. Biol. Chem. 280, 36560–36566 (2005).
36. Meylan, E. et al. RIP1 is an essential mediator of Toll-like receptor 3-induced
NF-kB activation. Nat. Immunol. 5, 503–507 (2004).
ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms3583
18 NATURE COMMUNICATIONS | 4:2583 |DOI: 10.1038/ncomms3583 | www.nature.com/naturecommunications
& 2013 Macmillan Publishers Limited. All rights reserved.
37. Chang, M., Jin, W. & Sun, S. C. Peli1 facilitates TRIF-dependent Toll-like
receptor signalling and proinflammatory cytokine production. Nat. Immunol.
10, 1089–1095 (2009).
38. Moynagh, P. N. The Pellino family: IRAK E3 ligases with emerging roles in
innate immune signalling. Trends Immunol. 30, 33–42 (2009).
39. Schauvliege, R., Janssens, S. & Beyaert, R. Pellino proteins: novel players in TLR
and IL-1R signalling. J. Cell Mol. Med. 11, 453–461 (2007).
40. Lin, C. C., Huoh, Y. S., Schmitz, K. R., Jensen, L. E. & Ferguson, K. M. Pellino
proteins contain a cryptic FHA domain that mediates interaction with
phosphorylated IRAK1. Structure 16, 1806–1816 (2008).
41. Schauvliege, R., Janssens, S. & Beyaert, R. Pellino proteins are more than
scaffold proteins in TLR/IL-1R signalling: a role as novel RING E3-ubiquitin-
ligases. FEBS Letts 580, 4697–4702 (2006).
42. Butler, M. P., Hanly, J. A. & Moynagh, P. N. Kinase-active interleukin-1
receptor-associated kinases promote polyubiquitination and degradation
of the Pellino family: direct evidence for PELLINO proteins being ubiquitin-
protein isopeptide ligases. J. Biol. Chem. 282, 29729–29737 (2007).
43. Ordureau, A. et al. The IRAK-catalysed activation of the E3 ligase function of
Pellino isoforms induces the Lys63-linked polyubiquitination of IRAK1.
Biochem. J. 409, 43–52 (2008).
44. Jiang, Z. et al. Pellino 1 is required for interleukin-1 (IL-1)-mediated signaling
through its interaction with the IL-1 receptor-associated kinase 4 (IRAK4)-
IRAK-tumor necrosis factor receptor-associated factor 6 (TRAF6) complex. J.
Biol. Chem. 278, 10952–10956 (2003).
45. Yu, K. Y. et al. Cutting edge: mouse pellino-2 modulates IL-1 and
lipopolysaccharide signaling. J. Immunol. 169, 4075–4078 (2002).
46. Siednienko, J. et al. Pellino3 targets the IRF7 pathway and facilitates
autoregulation of TLR3- and viral-induced expression of type I interferons.
Nat. Immunol. 13, 1055–1062 (2012).
47. Feoktistova, M. et al. cIAPs block Ripoptosome formation, a RIP1/caspase-8
containing intracellular cell death complex differentially regulated by cFLIP
isoforms. Mol. Cell 43, 449–463 (2011).
48. Tenev, T. et al. The Ripoptosome, a signaling platform that assembles
in response to genotoxic stress and loss of IAPs. Mol. Cell 43, 432–448
(2011).
49. Zheng, L. et al. Competitive control of independent programs of tumour
necrosis factor receptor-induced cell death by TRADD and RIP1.Mol. Cell Biol.
26, 3505–3513 (2006).
50. Wong, W. W. et al. RIPK1 is not essential for TNFR1-induced activation of
NF-kB. Cell Death Differ. 17, 482–487 (2010).
51. Xiao, H. et al. Pellino 3b negatively regulates interleukin-1-induced TAK1-
dependent NF kappaB activation. J. Biol. Chem. 283, 14654–14664 (2008).
52. Chang, M. et al. The ubiquitin ligase Peli1 negatively regulates T cell activation
and prevents autoimmunity. Nat. Immunol. 12, 1002–1009 (2011).
53. Du, C., Fang, M., Li, Y., Li, L. & Wang, X. Smac a mitochondrial protein that
promotes cytochrome c-dependent caspase activation by eliminating IAP
inhibition. Cell 102, 33–42 (2000).
54. Chai, J. et al. Structural and biochemical basis of apoptotic activation by Smac/
DIABLO. Nature 406, 855–862 (2000).
55. Li, L. et al. A small molecule Smac mimic potentiates TRAIL- and TNFalpha-
mediated cell death. Science 305, 1471–1474 (2004).
56. Varfolomeev, E. et al. IAP antagonists induce autoubiquitination of c-IAPs,
NF-kappaB activation, and TNFalpha-dependent apoptosis. Cell 131, 669–681
(2007).
57. Vince, J. E. et al. IAP antagonists target cIAP1 to induce TNFalpha-dependent
apoptosis. Cell 131, 682–693 (2007).
58. Tenev, T. et al. The Ripoptosome, a signaling platform that assembles in
response to genotoxic stress and loss of IAPs. Mol. Cell 43, 432–448 (2011).
59. Feoktistova, M. et al. cIAPs block Ripoptosome formation, a RIP1/caspase-8
containing intracellular cell death complex differentially regulated by cFLIP
isoforms. Mol. Cell 43, 449–463 (2011).
60. Moynagh, P. N. Peli1 (rel)ieves autoimmunity. Nat. Immunol. 12, 927–929 (2011).
Acknowledgements
This work was funded by Science Foundation Ireland (07/IN.1/B972). We thank Brian
Cloak for technical assistance with photomicroscopy.
Author Contributions
S.Y. developed the concept, designed and performed experiments, analysed the data and
prepared the figures; B.W. designed and performed experiments and analysed the data;
L.S.T. generated the expression constructs encoding the FHA mutants of Pellino3; J.S.
was responsible for breeding and genotyping mice and preparing lentivirus encoding
shRNAs. J.J.C. performed general pathology screening and the pathology-related
experiments on liver samples; P.N.M. conceived the study, supervised the project, ana-
lysed the data and wrote the manuscript.
Additional information
Supplementary Information accompanies this paper at http://www.nature.com/
naturecommunications
Competing financial interests: The authors declare no competing financial interests.
Reprints and permission information is available online at http://npg.nature.com/
reprintsandpermissions/
How to cite this article: Yang, S. et al. Pellino3 targets RIP1 and regulates the pro-
apoptotic effects of TNF-a. Nat. Commun. 4:2583 doi: 10.1038/ncomms3583 (2013).
NATURE COMMUNICATIONS | DOI: 10.1038/ncomms3583 ARTICLE
NATURE COMMUNICATIONS | 4:2583 | DOI: 10.1038/ncomms3583 | www.nature.com/naturecommunications 19
& 2013 Macmillan Publishers Limited. All rights reserved.
